This activity is supported by an educational grant from AstraZeneca, Bristol-Myers Squibb, Celgene, Lilly, and Merck.

Diagnosis and Treatment of Adenocarcinomas and Squamous Cell Carcinoma of the Lung

Millie Das, MD
Stanford University and VA Palo Alto

Alison Holmes Tisch, MSN, RN, ANP-BC, AOCNP®
Stanford Cancer Center

Following years in which there were only modest gains in treatment options for non–small cell lung cancer, the number of drugs approved in the past 5 years is unprecedented. Recognition of targetable mutations and immunogenicity of lung cancer now impact treatment decisions. This educational activity will provide the advanced practitioner with updates on the latest research, current guidelines in the diagnosis and workup, as well as information on novel treatments and side effect management to ensure the best outcomes for patients with NSCLC.



 

Download Podcast

   To claim credit for podcast click here
 
 

Download Transcript

 
 

Download Slides

 
 

Download Slides & Transcripts

   To claim credit for the slides & transcript click here





These CE/CME/CEU accredited activities are jointly provided by

JADPRO Logo    Harborside Press Logo    APSHO Logo    Annenberg Logo
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here